Table 2. Rotavirus vaccines and relative costs according to continents.
| Questions | Total (n = 49) | Africa (n = 10) | Asia (n = 13) | Europe (n = 20) | North America (n = 3) | South America (n = 3) | p |
|---|---|---|---|---|---|---|---|
| Inclusion in NIS (n, %) | 27 (55.1) | 8 (80) | 5 (38.4)b | 9 (45)b | 3 (100) | 2 (66.6) | 0.116 |
| Available vaccine | |||||||
| Rotarix (n, %) | 40 (81.6) | 7 (70) | 10 (76.9) | 17 (85) | 3 (100) | 3 (100) | 0.627 |
| RotaTeq (n, %) | 38 (77.5) | 3 (30) | 11 (84.6) | 18 (90) | 3 (100) | 3 (100) | 0.002 |
| Other (n, %) | 2 (4) | 0 (0) | 2 (15.3) | 0 (0) | 0 (0) | 0 (0) | 0.217 |
| None (n, %) | 3 (6.1) | 1 (10) | 2 (18.2) | 0 (0) | 0 (0) | 0 (0) | 0.422 |
| Costs in USD | |||||||
| Rotarix (mean + SD) | 103.8 (70⋅1) | 12.6 (18⋅5) | 80 (56.1) | 140.6 (56.4) | 182 (45.3) | 57⋅5 (61.5) | <0.001 |
| RotaTeq (mean + SD) | 176.8 (267⋅4) | 15 (NA) | 84.9 (47⋅8) | 253.2 (363⋅3) | 187.8 (53⋅4) | 125.5 (44.5) | 0.64 |
| Other (mean + SD) | 37.5 (48⋅8) | – | 37.5 (48.8) | – | – | – | NA |
| Payment charged to: | |||||||
| Family (n, %) | 21 (42.8) | 2 (20) | 8 (61.5) | 10 (50) | 0 (0)a | 1 (33.3) | 0.149 |
| Government (n, %) | 19 (38.7) | 4 (40) | 3 (23) | 7 (35) | 3 (100) | 2 (66.6) | 0.054 |
| GAVI Alliance (n, %) | 5 (10.2) | 4 (40) | 1 (7.6) | 0 (0) | 0 (0)a | 0 (0) | 0.014 |
| Insurance (n, %) | 4 (8.1) | 0 (0) | 1 (9) | 3 (15) | 0 (0)a | 0 (0) | 0.638 |
| No answer | 1 (2.0) | 0 (0) | 1 (9) | 0 (0) | 0 (0) | 0 (0) | NA |
NIS = National Immunization Schedule, NA = Not assessable.
a
Private Insurance may cover the cost of vaccination.
b
One country changed recommendation in 2015–2016 (see text).